| Steven R Shelton, MD | |
|
510 Spring St, Jeffersonville, IN 47130-3554 | |
| (812) 282-1888 | |
| (812) 218-9318 |
| Full Name | Steven R Shelton |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 39 Years |
| Location | 510 Spring St, Jeffersonville, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215934310 | NPI | - | NPPES |
| 2444452000 | Other | KY | PASSPORT ADVANTAGE |
| CK2274 | Other | KY | RAILROAD MEDICARE GROUP # |
| P00289126 | Other | KY | RAILRAOD MEDICARE |
| 160780 | Other | IN | MEDICARE GROUP |
| 2444451000 | Other | KY | PASSPORT GROUP |
| 82900176 | Medicaid | KY | |
| CG3623 | Other | IN | RAILROAD MEDICARE GROUP # |
| 65927857 | Medicaid | KY | |
| 78903689 | Medicaid | KY | |
| 1063415297 | Other | PV GROUP NPI | |
| 64870587 | Medicaid | KY | |
| 6764 | Other | KY | MEDICARE GROUP # |
| 000000042717 | Other | ANTHEM | |
| 100386460 | Other | IN | INDIANA MEDICAID GROUP # |
| 160860 | Other | IN | MEDICARE GROUP # |
| 260033017 | Other | IN | RAILROAD MEDICARE |
| 000000056294 | Other | ANTHEM GROUP | |
| 100076220A | Medicaid | IN | |
| 50704000 | Other | MAGELLAN GROUP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 01037556 (Indiana) | Primary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 24712 (Kentucky) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St Vincent Salem | Salem, IN | Hospital |
| Saint Joseph Berea | Berea, KY | Hospital |
| Ascension St Vincent Jennings | North vernon, IN | Hospital |
| St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Extended Care Specialists, Inc | 2466407713 | 183 |
| Lake Substance Abuse Solutions Llc | 8123440401 | 11 |
| Extended Care Specialists, Inc | 2466407713 | 183 |
| Lake Substance Abuse Solutions Llc | 8123440401 | 11 |
| St Luke's Physician Group Inc | 6709798333 | 1739 |
| Extended Care Specialists, Inc | 2466407713 | 183 |
News Archive
An international research team led by Wolfgang Weninger, who has been Head of MedUni Vienna's Department of Dermatology since 1 September, has discovered a previously unknown virus that acts as a "driver" for certain kidney diseases (interstitial nephropathy).
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new pre-clinical data demonstrating the inhibitory effects of GFT505 on the proliferation of cancer cells of different origins.
Isosec, the market-leading provider of security, authentication and workflow solutions to the NHS and Healthcare sectors, today announces the launch and availability of the first Virtual Smartcard for NHS Trusts and clinicians.
Researchers at The Ohio State University are working on a new way to treat drug-resistant cancer that the ancient Greeks would approve of-only it's not a Trojan horse, but DNA that hides the invading force.
› Verified 3 days ago
| Entity Name | Ridge Outpatient Counseling, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922214956 PECOS PAC ID: 5991690471 Enrollment ID: O20040216000693 |
News Archive
An international research team led by Wolfgang Weninger, who has been Head of MedUni Vienna's Department of Dermatology since 1 September, has discovered a previously unknown virus that acts as a "driver" for certain kidney diseases (interstitial nephropathy).
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new pre-clinical data demonstrating the inhibitory effects of GFT505 on the proliferation of cancer cells of different origins.
Isosec, the market-leading provider of security, authentication and workflow solutions to the NHS and Healthcare sectors, today announces the launch and availability of the first Virtual Smartcard for NHS Trusts and clinicians.
Researchers at The Ohio State University are working on a new way to treat drug-resistant cancer that the ancient Greeks would approve of-only it's not a Trojan horse, but DNA that hides the invading force.
› Verified 3 days ago
| Entity Name | Eventus Wholehealth Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548759392 PECOS PAC ID: 6002169539 Enrollment ID: O20190312002589 |
News Archive
An international research team led by Wolfgang Weninger, who has been Head of MedUni Vienna's Department of Dermatology since 1 September, has discovered a previously unknown virus that acts as a "driver" for certain kidney diseases (interstitial nephropathy).
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new pre-clinical data demonstrating the inhibitory effects of GFT505 on the proliferation of cancer cells of different origins.
Isosec, the market-leading provider of security, authentication and workflow solutions to the NHS and Healthcare sectors, today announces the launch and availability of the first Virtual Smartcard for NHS Trusts and clinicians.
Researchers at The Ohio State University are working on a new way to treat drug-resistant cancer that the ancient Greeks would approve of-only it's not a Trojan horse, but DNA that hides the invading force.
› Verified 3 days ago
| Entity Name | Lifesource Of North Carolina |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538728183 PECOS PAC ID: 7416132428 Enrollment ID: O20190620002144 |
News Archive
An international research team led by Wolfgang Weninger, who has been Head of MedUni Vienna's Department of Dermatology since 1 September, has discovered a previously unknown virus that acts as a "driver" for certain kidney diseases (interstitial nephropathy).
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new pre-clinical data demonstrating the inhibitory effects of GFT505 on the proliferation of cancer cells of different origins.
Isosec, the market-leading provider of security, authentication and workflow solutions to the NHS and Healthcare sectors, today announces the launch and availability of the first Virtual Smartcard for NHS Trusts and clinicians.
Researchers at The Ohio State University are working on a new way to treat drug-resistant cancer that the ancient Greeks would approve of-only it's not a Trojan horse, but DNA that hides the invading force.
› Verified 3 days ago
| Entity Name | Extended Care Specialists, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134146079 PECOS PAC ID: 2466407713 Enrollment ID: O20190703001141 |
News Archive
An international research team led by Wolfgang Weninger, who has been Head of MedUni Vienna's Department of Dermatology since 1 September, has discovered a previously unknown virus that acts as a "driver" for certain kidney diseases (interstitial nephropathy).
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new pre-clinical data demonstrating the inhibitory effects of GFT505 on the proliferation of cancer cells of different origins.
Isosec, the market-leading provider of security, authentication and workflow solutions to the NHS and Healthcare sectors, today announces the launch and availability of the first Virtual Smartcard for NHS Trusts and clinicians.
Researchers at The Ohio State University are working on a new way to treat drug-resistant cancer that the ancient Greeks would approve of-only it's not a Trojan horse, but DNA that hides the invading force.
› Verified 3 days ago
| Entity Name | Lake Substance Abuse Solutions Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124598669 PECOS PAC ID: 8123440401 Enrollment ID: O20200715001084 |
News Archive
An international research team led by Wolfgang Weninger, who has been Head of MedUni Vienna's Department of Dermatology since 1 September, has discovered a previously unknown virus that acts as a "driver" for certain kidney diseases (interstitial nephropathy).
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new pre-clinical data demonstrating the inhibitory effects of GFT505 on the proliferation of cancer cells of different origins.
Isosec, the market-leading provider of security, authentication and workflow solutions to the NHS and Healthcare sectors, today announces the launch and availability of the first Virtual Smartcard for NHS Trusts and clinicians.
Researchers at The Ohio State University are working on a new way to treat drug-resistant cancer that the ancient Greeks would approve of-only it's not a Trojan horse, but DNA that hides the invading force.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven R Shelton, MD 510 Spring St, Jeffersonville, IN 47130-3554 Ph: (812) 282-1888 | Steven R Shelton, MD 510 Spring St, Jeffersonville, IN 47130-3554 Ph: (812) 282-1888 |
News Archive
An international research team led by Wolfgang Weninger, who has been Head of MedUni Vienna's Department of Dermatology since 1 September, has discovered a previously unknown virus that acts as a "driver" for certain kidney diseases (interstitial nephropathy).
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new pre-clinical data demonstrating the inhibitory effects of GFT505 on the proliferation of cancer cells of different origins.
Isosec, the market-leading provider of security, authentication and workflow solutions to the NHS and Healthcare sectors, today announces the launch and availability of the first Virtual Smartcard for NHS Trusts and clinicians.
Researchers at The Ohio State University are working on a new way to treat drug-resistant cancer that the ancient Greeks would approve of-only it's not a Trojan horse, but DNA that hides the invading force.
› Verified 3 days ago
Geoffrey Jeyasingham, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 301 Gordon Gutmann Blvd Ste 101, Jeffersonville, IN 47130 Phone: 812-282-4844 Fax: 812-282-6248 | |
Leah G Dickerson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 460 Spring St, Jeffersonville, IN 47130 Phone: 812-280-2080 | |
Steven G Gibson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 510 Spring St, Jeffersonville, IN 47130 Phone: 812-282-1888 Fax: 812-285-8892 | |
Dr. Mashiur Rahman Khan, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2420 E 10th St, Jeffersonville, IN 47130 Phone: 812-282-8248 | |
Sheryl Schneider, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 460 Spring St, Jeffersonville, IN 47130 Phone: 812-280-2080 | |
Carol Hammerbeck, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2780 Jefferson Centre Way Unit 104, Jeffersonville, IN 47130 Phone: 812-288-8622 Fax: 812-288-8632 |